← Leaderboards
Karen Macleod
Amprion, Inc.
$2,304,786
Attributed
$2,304,786
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $809.6K · FY2020–22$1M$750K$500K$250K$0
'20
'21
'22
Funding mix
By agency
NIH$2,304,786 · 1
By mechanism
U44$2,304,786 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Early Diagnosis”
- Ross D McDonald · Florida State University$26,502,247
- Eric C Palm · Florida State University$26,502,247
- Michael W Rabin · Florida State University$26,502,247
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- Bryan Faller · Decatur Memorial Hospital$26,356,185
- George Robert Painter · University Of Alabama At Birmingham$25,957,440
Research focus
Early DiagnosisAmyloidAlpha SynucleinAtrophicBaseBiochemicalAmyloid Beta-ProteinAlzheimer&AposBody FluidsCalibrationCerebrospinal FluidCerebrospinal Fluid ProteinsCharacteristicsData AnalysesBiologicalDesignDetectionBiological MarkersDiagnosisDiagnostic BiomarkerDiagnostic TestsDisease ProgressionDyesEffectiveness Evaluation
Grant awards (3)
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease$809,593
U44 · FY2022 · NS · contact PI
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease$809,593
U44 · FY2021 · NS · contact PI
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease$685,600
U44 · FY2020 · NS · contact PI